Several prior studies have demonstrated that patients with decreased CRTAC1 expression exhibit an unfavorable prognosis in glioma, bladder cancer, and gastric adenocarcinoma9,10,24. This evidence concerns the gene CRTAC1 and central nervous system cancer.